Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

19.00
Delayed Data
As of Feb 17
 0.00 / 0.00%
Today’s Change
7.86
Today|||52-Week Range
19.90
+26.25%
Year-to-Date

Today’s Trading

Previous close19.00
Today’s open19.00
Day’s range18.60 - 19.25
Volume416,716
Average volume (3 months)617,567
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+30.89%
Earnings growth (this year)+12.64%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.58%
P/E ratioNM
Price/Sales10.45
Price/Book3.54

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.04-0.08%
BPMCBlueprint Medicines ...-0.54-1.50%
CHRSCoherus BioSciences ...-0.50-2.17%
HALOHalozyme Therapeutic...+0.05+0.40%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$89.7M
Annual profit (last year)-$83.3M
Net profit margin-92.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs